 |
Catalogue |
 |
|
Main Products |
|
|
|
|
Products |
|
No. |
Product Name |
CAS No. |
Spec |
Price |
|
| A-2349 |
JSH 23, 99.7% |
749886-87-1 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-0065 |
Kobe 0065, 99.1% |
436133-68-5 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2319 |
L 002(NSC 764414), 99.6% |
321695-57-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2297 |
LH 846, 99.1% |
639052-78-1 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2354 |
Linagliptin(BI 1356), 99.8% |
668270-12-0 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2357 |
LXR 623(WAY 252623), 99.4% |
875787-07-8 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2362 |
LY 333531 HCl(Ruboxistaurin), 99.3% |
169939-93-9 |
|
|
| A-2309 |
ML 323, 100% |
1572414-83-5 |
|
|
| A-2358 |
Mps1-IN-2, 98.5% |
1228817-38-6 |
|
|
| A-2327 |
NEO 212(TMZ-POH), 99.1% |
1361198-79-9 |
|
|
| A-2359 |
Nexturastat A , 99.2% |
1403783-31-2 |
|
|
| A-2148 |
PF 04447943(PF 4447943), 99.8% |
1082744-20-4 |
|
|
| A-2020 |
PF 4693627(PF 04693627), 100%|>98%d.e |
1312815-93-2 |
|
|
| A-2295 |
PPQ 102, 99.8% |
931706-15-9 |
|
|
| A-2299 |
Remodelin, 99.2% |
949912-58-7 |
|
|
| A-2352 |
Roflumilast(Daxas), 100% |
162401-32-3 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2370 |
SB-3CT, 99.1% |
292605-14-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1799 |
SSR 125543A(SSR 125543 HCl), 98.7% |
321839-75-2 |
|
|
| A-2314 |
Stattic, 99.8% |
19983-44-9 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2128 |
Stem Cell 2i inhibitor Set, >99%(PD 0325901+CHIR 99021) |
391210-10-9+252917-06-9 |
| 2+2mg |
Inquiry |
| 5+5mg |
Inquiry |
|
|
|
|
|
